Phase 3 PCO Clinical Trials
4 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–4 of 4 trials
Recruiting
Phase 3
Role of Semaglutide in Restoring Ovulation in Youth and Adults With Polycystic Ovary Syndrome
ObesePCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries
University of Colorado, Denver80 enrolled1 locationNCT05819853
Recruiting
Phase 2Phase 3
Semaglutide in Women With Polycystic Ovary Syndrome and Obesity
ObesityPolycystic Ovary Syndrome (PCOS) Women
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh30 enrolled1 locationNCT06896981
Recruiting
Phase 3
Diosmin plus cabergoline for prevention of Ovarian Hyperstimulation Syndrome in high-risk women undergoing intracytoplasmic sperm injection (ICSI)
Ovarian Hyperstimulation SyndromePCO (polycystic ovarian syndrome)infertile women
khalid abd aziz mohamed250 enrolled1 locationACTRN12614000535673
Completed
Phase 3Phase 4
Gonadotropin-releasing hormone (GnRH) antagonist vs. gonadotropin-releasing hormone agonist protocol for in vitro fertilization in non-obese patients with Polycystic Ovary Syndrome (PCOS). A prospective randomized study.
GnRH antagonists in PCOS
State Committee for Scientific Research70 enrolled1 locationACTRN12607000636459